TMCnet News
Therapure Biomanufacturing Receives 2017 CMO Leadership Individual Attribute Awards for Capabilities and Staff CharacteristicsTherapure Biomanufacturing, the contract development and manufacturing division of Therapure Biopharma Inc., announces that it has received The CMO Leadership Individual Attribute awards in four areas: Strength of Science, State of the Art, Accessible Senior Management and Cultural Fit. The Life Science Leader's annual CMO Leadership Awards Ceremony was held March 22, 2017 in New York City with winners chosen based on Industry Standard Research's (ISR's) Biologic API Contract Manufacturer Quality Benchmarking report. The CMO Leadership Awards ensure that quality ratings come from companies that have worked with the CMO/CDMO within the last 18 months and that results are based on experiential data. "Each year, the CMO Leadership Awards recognize the success that individual drug development and manufacturing organizations have in serving the needs of their biotechnology and pharmaceutical customers and partners," said Louis Garguilo, executive editor of Life Science Leader magazine and OutsourcedPharma.com. "An award in any of the categories adds to the distinction and reputation of CMOs within the greater drug discovery, development, manufacturing and marketingindustries." "We are honoured and pleased to be recognized by our clients for capabilities and staff characteristic," says Therapure's President and CEO, Nick Green. "This achievement is only possible through the continued diligence of our employees, who are passionate about developing and manufacturing the highest quality biotherapeutics for our clients and their patients. That said, this is more than an award, it provides us with client feedback that helps us manage and improve the client's experience throughout our organization."
About Therapure Biomanufacturing For more information on our CDMO services, please visit http://www.therapurebio.com/CDMO/.
About Therapure Biopharma Inc. For more information on Therapure Biopharma Inc., please visit www.therapurebio.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170323005986/en/ |